When each batch has a patient count of one, established segregation and traceability principals for biologics offer a useful roadmap.
- You Can't CAPA What You Can't Locate
- The Real Value Of Continuous Bioprocessing Is In Connected Unit Operations
- Why CMC Must Shape Critical Decisions Early In Development
- Developing Your Vapor Phase Hydrogen Peroxide Cycle
- Closing The Gap Between Modeling And GMP Predictive Control
- IT/OT Convergence Could Lighten Biopharma's Automation Burden
- Beyond The Plate Count: How To Build A Defensible Environmental Monitoring Trend Review
EDITOR'S DESK
-
Contextualizing Data To Enable AI And Prevent Knowledge Leaks
Bioprocess Online's Tyler Menichiello interviews Martin Kockx, a principal manufacturing systems engineer at Vertex Pharmaceuticals, on his presentation at 2026 BPI, “Transforming Biomanufacturing: Why Architecture Must Precede Analytics."
An interview with Jacqualyn Schulman, Ph.D., a principal scientist at Bristol Myers Squibb (BMS), on her presentation at BPI 2026, “Fast-Tracking CHO Cell Line Development Using Integrated Engineering Strategies.”
This article captures key takeaways from a BioProcess International keynote by Preeya Boppana, director of MSAT process analytics and laboratories at AstraZeneca, titled “Transforming Biologics Manufacturing: Leveraging Predictive Analytics and Advanced Process Control for Next-Generation Operations.”
Regulatory compliance and cGMP manufacturing expert Tatyana Matveeva, Ph.D., explains the role and importance of a quality unit in an organization, as well as what happens when it’s compromised.
Experts discuss where productivity gains can be achieved and how development teams should seek to improve process performance in this recap of the Bioprocess Online Live event "The Levers And Tradeoffs That Drive Process Productivity."
GUEST COLUMNISTS
-
You Can't CAPA What You Can't Locate
Don’t reinvent the wheel — adapt it. Locate before you correct, because where a failure appears isn’t necessarily where it gets fixed.
-
Why CMC Must Shape Critical Decisions Early In Development
Case studies reveal the gap between research progress and clinical readiness. In these stories, earlier CMC involvement might have saved resources and staved off delays.
-
Developing Your Vapor Phase Hydrogen Peroxide Cycle
Vapor phase hydrogen peroxide has been used for decades as a surface decontaminant in pharma/biotech, but there has been little guidance on how to establish the parameters. Here's an industry consensus from BioPhorum.
-
Closing The Gap Between Modeling And GMP Predictive Control
Predictive control offers opportunities to improve process consistency, reduce variability, and respond to changing manufacturing conditions before they cause deviations.
-
IT/OT Convergence Could Lighten Biopharma's Automation Burden
Integration lets frameworks talk to each other through middleware. Convergence brings them under the same architecture, which can can reduce costs and maintenance.
-
Beyond The Plate Count: How To Build A Defensible Environmental Monitoring Trend Review
Determining whether a drug manufacturing environment is stable, drifting, or developing a recurring loss-of-control signal requires integrated trend evaluation.
-
Want More Sustainable Biopharma Packaging? Try These Levers
Biopharmaceutical packaging optimization must not compromise the goods inside or compliance, so sustainable packaging developers might need to think outside the box.
-
What Europe's Draft Annex 22 Actually Asks Of Human Oversight Of AI
The European Commission and the Pharmaceutical Inspection Co-operation Scheme (PIC/S) consulted on draft Annex 22, Artificial Intelligence. Here's what you should know.
BIOPROCESSING WHITE PAPERS
-
Navigating Digital Transformation For Pharmaceutical CDMOs
Discover how CDMOs can modernize operations, safeguard data integrity, and improve audit readiness with practical strategies for connecting systems and reducing validation burdens.
-
Incremental Adoption Of A Modular Operations Platform1/31/2025
Discover the potential of a modular operations platform that scales the benefits of digitalization and aids organizations in implementing a unified data strategy to realize the full potential of smart manufacturing.
-
If You Can't Win The Game, Change It12/11/2024
Explore how eData sharing is used in the biopharma market, enabling standardized, collaborative supply chains that reduce risks and enhance visibility while improving capacity planning.
-
A Guide To Process Transparency In Custom Lab Automation Development3/16/2026
Discover a practical guide to building custom automation systems with clarity and confidence, as well as how transparent processes reduce risk, prevent misalignment, and support reliable testing.
-
The Essential Ingredient For GxP Training Innovation6/4/2026
Advanced learning tools depend entirely on the health of the underlying training matrix. Establish a clean, data-driven framework to reduce compliance risks and recover lost operational hours.
-
From Laboratory To Launchpad: Japan's Cell And Gene Therapy Ecosystem Hits Its Stride10/21/2026
Japan is emerging as a credible cell and gene therapy hub as regulation, manufacturing, and capital advance, despite gaps in funding, talent, risk culture, and language.
BIOPROCESSING APP NOTES & CASE STUDIES
- Supply Chain Diversification In Biopharmaceutical Manufacturing
- De-Risking Glycosylation: Scaling In Vitro Glycoengineering From Lab To GMP
- A Universal Workflow Approach For Single Cell Mass Spectrometry Based Proteomics
- Measuring Scanning Motion Flatness With AFM
- The Role Of Peptones In Boosting Monoclonal Antibody Production
- The Real Value Of Continuous Bioprocessing Is In Connected Unit Operations
- On The Ground At BPI: Where AI Dreams Meet Operational Reality
- On The Ground At BPI: Tatyana Matveeva, Ph.D., On Distributed Manufacturing Models
- Contextualizing Data To Enable AI And Prevent Knowledge Leaks
- On The Ground At BPI: Jacqualyn Schulman, Ph.D., On Accelerating Clonal CLD
- AstraZeneca's Focus On Predictive Control, Semi-Autonomous Processing
- Prioritizing Quality Over Everything
EDITORIAL COLLECTIONS KNOWLEDGE CENTER
Editorial Collections are subscriber-only, curated resources that combine expert interviews, feature articles, and industry analysis to help readers better understand emerging trends, operational challenges, regulatory developments, and best practices shaping the biopharma industry.
More Editorial CollectionsFEATURED PRODUCTS AND SERVICES
ON-DEMAND WEBINARS
- From Clinical Success To Commercial Readiness
- Operation Readiness Strategy To Improve Project Delivery And Startup Success
- Bacterial Retention Testing: Demonstrating Sterilizing Filter Performance
- Decoding Biologics Tech Transfer: Process Performance Across Sites And Scales
- Planning For Scale From The Start: Where Early Development Decisions Create Commercial Risk
INDUSTRY NEWS
NEWSLETTER ARCHIVE
- 11.19.26 -- Contextualizing Data To Enable AI And Prevent Knowledge Leaks
- 11.18.26 -- Is It Time To Rethink Your Protein Expression Strategy?
- 11.18.26 -- Will Your Next-Gen Conjugate Survive Scale-Up?
- 11.18.26 -- Developing Your Vapor Phase Hydrogen Peroxide Cycle
- 11.17.26 -- Turning Data Into Development Confidence

